Clifford Swan Investment Counsel LLC Gilead Sciences, Inc. Transaction History
Clifford Swan Investment Counsel LLC
- $2.66 Billion
- Q2 2024
A detailed history of Clifford Swan Investment Counsel LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Clifford Swan Investment Counsel LLC holds 65,932 shares of GILD stock, worth $5.53 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
65,932
Previous 69,864
5.63%
Holding current value
$5.53 Million
Previous $5.12 Million
11.61%
% of portfolio
0.17%
Previous 0.19%
Shares
29 transactions
Others Institutions Holding GILD
# of Institutions
1,878Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$10.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$9.68 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.4 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.07 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$4.98 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $105B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...